{
  "timestamp": "2025-04-19 14:51:33",
  "phase": "Evolution",
  "round": 2,
  "elo_score": null,
  "content": "DSB accumulation triggers senescence-associated secretory phenotype (SASP), which creates a pro-tumorigenic microenvironment, and senolytic therapies targeting SASP-secreting cells can reduce tumor promotion.  \n*Supporting evidence:* SASP factors promote tumor growth and are induced by persistent DNA damage [Coppe 2010]. Senolytics can limit tumorigenic effects of SASP [Kirkland 2017, J Am Geriatr Soc].\n\n---"
}